Press Releases Press Releases Year None20192018 June 21, 2019 Stoke Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares June 18, 2019 Stoke Therapeutics Announces Pricing of Initial Public Offering June 14, 2019 Stoke Therapeutics Appoints Jennifer Burstein to its Board of Directors March 19, 2019 Stoke Therapeutics Appoints Industry Veteran Stephen Tulipano as Chief Financial Officer March 7, 2019 Stoke Therapeutics to Present on First Disease-Modifying Therapies for Genetic Epilepsies at Cowen and Company Annual Health Care Conference February 26, 2019 Behind The SeizureTM Program Expansion Helps Speed the Diagnosis of Genetic Epilepsy in Younger Children Experiencing Unprovoked Seizures January 3, 2019 Stoke Therapeutics to Present on First Precision Treatments for Genetic Epilepsies at J.P. Morgan Healthcare Conference Toolkit Print Page Email Alerts Contact IR FAQ
Press Releases Year None20192018 June 21, 2019 Stoke Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares June 18, 2019 Stoke Therapeutics Announces Pricing of Initial Public Offering June 14, 2019 Stoke Therapeutics Appoints Jennifer Burstein to its Board of Directors March 19, 2019 Stoke Therapeutics Appoints Industry Veteran Stephen Tulipano as Chief Financial Officer March 7, 2019 Stoke Therapeutics to Present on First Disease-Modifying Therapies for Genetic Epilepsies at Cowen and Company Annual Health Care Conference February 26, 2019 Behind The SeizureTM Program Expansion Helps Speed the Diagnosis of Genetic Epilepsy in Younger Children Experiencing Unprovoked Seizures January 3, 2019 Stoke Therapeutics to Present on First Precision Treatments for Genetic Epilepsies at J.P. Morgan Healthcare Conference
June 21, 2019 Stoke Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
March 19, 2019 Stoke Therapeutics Appoints Industry Veteran Stephen Tulipano as Chief Financial Officer
March 7, 2019 Stoke Therapeutics to Present on First Disease-Modifying Therapies for Genetic Epilepsies at Cowen and Company Annual Health Care Conference
February 26, 2019 Behind The SeizureTM Program Expansion Helps Speed the Diagnosis of Genetic Epilepsy in Younger Children Experiencing Unprovoked Seizures
January 3, 2019 Stoke Therapeutics to Present on First Precision Treatments for Genetic Epilepsies at J.P. Morgan Healthcare Conference